Extraordinary Professorship for Martin Regensburger
In recognition of his outstanding achievements in research and teaching, our ACS Martin Regensburger has been awarded an early appointment as an extraordinary professor by FAU Erlangen-Nürnberg. This underscores the importance of his research focus: neurodegenerative diseases such as ALS and Parkinson’s. As an Advanced Clinician Scientist, he applies the results of his research directly to clinical care at the University Hospital Erlangen through translational approaches. Congratulations, Martin – the whole iIMMUNE team is delighted for you!
Network meeting of all BMFTR-ACS programs 2026 in Essen
The 3rd network meeting of all BMFTR-funded ACS sites took place in Essen on March 19–20, 2026 - it generated a lot of momentum! It was a wonderful opportunity for exchange, featuring very interesting presentations and stimulating discussions. Many thanks to the coordinators from Essen and Würzburg for the excellent organization!
Help after 30 years of tremor
For 30 years, patient Irene F. suffered from essential tremor that could not be treated. In this article from ‘Gesundheit erlangen’, you can read how she is now able to lead a new and largely tremor-free life after two operations and accompanying treatment carried out by our ACS Dr. Franziska Schmidt and Dr. Martin Regensburger. A wonderful story!
New ACS Fellow: Dr. Franziska Schmidt
We are delighted to welcome Dr Franziska Schmidt as a new fellow in the iIMMUNE_ACS programme! As a neurosurgeon, she is investigating inflammatory biomarkers in order to predict the success of deep brain stimulation treatment. She previously worked at Toronto Western Hospital in Canada. Welcome to the team, Franzi, we wish you every success!
